Ten Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2018

In this online program faculty discuss how to leverage 10 of the emerging and most clinically important biomarkers to optimize patient care across multiple tumor types from solid tumors to hematologic malignancies.

Learn about biomarkers agnostic to tumor type as well as an in-depth look at case studies in non-small-cell lung cancer acute myeloid leukemia and chronic lymphocytic leukemia for examples of personalized medicine in 2018.

Share

Program Content

Activities

10 Biomarkers: Cancer Care 2018
Ten Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2018
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2018

Expires: July 09, 2019

Activities

Biomarker: <I>FLT3</I>
Biomarker Summary: FLT3
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker:  <i>IDH1</i> and <i>IDH2</i>
Biomarker Summary: IDH1 and IDH2
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: MSI/MMR
Biomarker Summary: MSI/MMR
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: <i>ALK/ROS1</i>
Biomarker Summary: ALK/ROS1
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: TRK
Biomarker Summary: TRK
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: PD-L1
Biomarker Summary: PD-L1
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: <i>BRAF</I>
Biomarker Summary: BRAF
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: <em>BRCA1/2</em>
Biomarker Summary: BRCA1/2
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: <i>TP53</i> del(17p)
Biomarker Summary: TP53 mutations, deletion 17p
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Biomarker: <i>EGFR</i>
Biomarker Summary: EGFR
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2018

Expires: June 12, 2019

Activities

Checkpoints and DNA Repair
Understanding Immune Checkpoint Inhibition and DNA Repair Deficiencies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2018

Expires: June 03, 2019

Cell Communication and Tumor Growth
Therapeutically Actionable Targets Affecting Cellular Communication and Tumor Growth
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2018

Expires: June 03, 2019

Individualized AML Therapy
Individualized Therapy and Molecular Targeting in AML
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2018

Expires: June 03, 2019

CLL and del(17p)
CLL: Treatment Decisions Driven by del(17p)/TP53 Mutation
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2018

Expires: June 04, 2019

Lung Cancer Biomarkers
New Biomarker Insights to Optimize Treatment Decisions for Patients With Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2018

Expires: June 07, 2019

Faculty

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Todd M. Bauer, MD

Senior Investigator, Greco-Hainsworth Centers for Research
Tennessee Oncology, PLLC
Nashville, Tennessee

cover img faculity

Hagop M. Kantarjian, MD

Chairman, Department of Leukemia
Professor of Medicine
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

Agios Pharmaceuticals

Bayer Healthcare Pharma

Celgene TEXT Only

Foundation Medicine

Loxo Oncology

Merck Oncology